Last updated 33 days ago

Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

208 patients around the world
Available in Argentina, United States
Study duration per participant will be up to 44 weeks (Study A) and 32 weeks (Study B).
Sanofi
6Research sites
208Patients around the world
Requirements for the patient
To 90 Years
All Gender
Medical requirements
Sites
STAT Research - CABA
STAT Research - CABA
Recruiting
Av. Callao 875, CABA, Buenos Aires
Fundación CIDEA - Buenos Aires
Fundación CIDEA - Buenos Aires
Recruiting
Paraguay 2035, C1121ABE Cdad. Autónoma de Buenos Aires, Argentina
Centro de Alergia y Enfermedades Respiratorias - Buenos Aires
Recruiting
Luis María Drago 250, CABA, Buenos Aires
CONEXA Investigación Clínica S.A.
Recruiting
Pasaje Rivarola 111, Piso 3º, Oficina 9, CABA
Centro Médico - Buenos Aires Skin S.A. - CABA, Buenos Aires
Recruiting
Av. Córdoba 1184, CABA, Buenos Aires
Instituto Médico de la Fundación Estudios Clínicos - Rosario
Recruiting
Italia 428, Rosario - Santa Fe
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy